Is WELL Health (TSX:WELL) Stock a Buy After Q3 Earnings?

WELL Health (TSX:WELL) stock soared after the company reported a strong Q3. Physical in-clinic patient visits rebounded strongly following lockdowns.

| More on:
healthcare pharma

Image source: Getty Images

WELL Health Technologies (TSX:WELL) is an omnichannel digital health company that operates primary healthcare facilities and is the third-largest provider of digital electronic medical records (EMRs) in Canada in addition to being a national provider of telehealth services. The healthcare company owns and operates 20 medical clinics, provides digital EMR software and services to over 1,900 medical clinics across Canada, and is a majority owner of SleepWorks Medical. WELL Health stock price is about five times higher than at the start of the year.

WELL Health is led by Chairman and CEO Hamed Shahbazi, who sold his previous company, TIO Networks, to PayPal for more than $300 million.

The company is an M&A compounder, which can generate value in the massive healthcare market that is ripe for digital transformation. WELL has invested in a number of other technology assets.

The leadership has demonstrated an exceptional ability to execute disciplined accretive M&A and acquire valuable technology that can scale. Secular changes accelerated by the pandemic are strong favourable winds supporting WELL’s strategy to leverage technology and increase healthcare efficiency, thereby improving patient outcomes and generating shareholder value.

WELL Health stock soars on solid Q3 results

WELL Health stock soared by 7% shortly after the opening bell Thursday, as investors reacted positively to the company’s results in the third quarter of 2020.

WELL achieved record quarterly revenue of $12,245,735 and gross profit of $5,045,440, representing 50% and 75% year-over-year growth, respectively. WELL achieved digital services revenue of $2,484,862 in the third quarter, up 149% year over year. Combined with recently completed and announced acquisitions, WELL currently has an annualized revenue run-rate of approximately $68 million and is growing fast.

WELL’s positive Q3 results were driven by a significant increase in its clinical patient services revenue from Q2 2020 to Q3 2020 due to a return to physical clinic visits after lockdowns related to COVID-19. Meanwhile, the company’s virtual care revenue continued to grow in the quarter.

During the third quarter, WELL completed the acquisition of the Services division of Cycura Inc. and announced its entry into the U.S. market with a majority stake in Circle Medical Inc. After the end of the quarter, WELL completed the acquisition of DoctorCare Inc.; a controlling interest in Easy Allied Health Inc.; and its 100% acquisition of Insig Corporation, a leader in telehealth services in Canada — thereby significantly diversifying its activities into several growth-oriented business units.

Additionally, in the third quarter, the company launched its apps.health marketplace for healthcare professionals to navigate and interact with integrated EMR applications designed by third-party application developers. This market now offers 26 applications related to clinical efficiency and improved patient care.

WELL has a healthy balance sheet, with more than $100 million in cash and no debt following completion of $23 million private placement led by Sir Li Ka-shing in September and a recently completed $80.5 million bought deal financing closed on October 22, 2020.

WELL Health has plenty of upside

The company’s outlook for the fourth quarter of 2020 is enhanced with recent acquisitions of Cycura, Easy Allied, DoctorCare, INSIG, and the impending closing of the Circle Medical transaction. So far, in the fourth quarter of 2020, WELL has experienced steady growth in its patient service revenue with an increase of both in-clinic patient visits and virtual care consultations.

WELL’s objectives for the foreseeable future are as follows: it will achieve organic revenue growth from its operating activities; it will continue to follow a disciplined strategy for acquiring and allocating capital; and it will increase its market share and publicize its digital health initiatives.

Revenue is expected to increase by 37.2%, while earnings are expected to grow at a rate of 12.5% for fiscal 2020. WELL Health stock still has plenty of upside.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Stephanie Bedard-Chateauneuf has no position in any of the stocks mentioned. The Motley Fool owns shares of and recommends PayPal Holdings and recommends the following options: long January 2022 $75 calls on PayPal Holdings.

More on Investing

edit Jars of marijuana
Cannabis Stocks

Is Tilray Stock a Buy in the New Bullish Market?

Canadian cannabis producer Tilray has underperformed the broader markets in the last five years due to its weak fundamentals.

Read more »

Woman has an idea
Investing

3 No-Brainer Stocks to Buy With $200 Right Now

These three stocks are no-brainer buys, given their solid underlying businesses and healthy growth prospects.

Read more »

Investing

2 Stocks I’m Loading Up on in 2024

Alimentation Couche-Tard (TSX:ATD) and another stock that are getting too cheap after their latest corrections.

Read more »

grow money, wealth build
Dividend Stocks

1 Top Dividend Stock That Can Handle Any Kind of Market (Even Corrections)

While most dividend aristocrats can maintain their payouts during weak markets, very few can maintain a healthy valuation or bounce…

Read more »

Red siren flashing
Dividend Stocks

Income Alert: These Stocks Just Raised Their Dividends

Three established dividend-payers from different sectors are compelling investment opportunities for income-focused investors.

Read more »

online shopping
Tech Stocks

1 Hidden Catalyst That Could Ignite Shopify Stock

Here's why Shopify (TSX:SHOP) ought to remain a top growth stock investors continue to focus on for the long haul.

Read more »

Oil pumps against sunset
Energy Stocks

Is it Too Late to Buy Enbridge Stock?

Besides its juicy and sustainable dividends, Enbridge’s improving long-term growth prospects make it a reliable stock to hold for the…

Read more »

Man considering whether to sell or buy
Tech Stocks

WELL Stock: Buy, Sell, or Hold?

WELL stock has a lot of upside as the company is likely to continue to grow, posting positive earnings in…

Read more »